Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (466K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Antoniou, M.
Right arrow Articles by Grosveld, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoniou, M.
Right arrow Articles by Grosveld, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 3 721-729, Copyright © 1998 by Oxford University Press


ARTICLES

Efficient 3'-end formation of human beta-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reaction

M Antoniou, F Geraghty, J Hurst and F Grosveld
Department of Experimental Pathology, UMDS, Guy's Hospital, London Bridge, London SE1 9RT, UK. m.antoniou@umds.ac.uk

The second intron (betaIVS-II) of the human beta-globin gene is essential for the accumulation of stable cytoplasmic mRNA and is implicated in promoting efficient 3'-end formation. This report presents quantitative comparisons between betaIVS-II mutants at physiological levels of expression from within a natural chromatin context in vivo which further defines it's function. In marked contrast to a beta-globin gene lacking a second intron, two mutants defective in splicing (small size or a splice donor mutation), still undergo essentially normal levels of 3'-end formation and in the absence of exon skipping. Therefore, 3' cleavage of beta-globin transcripts requires the presence of betaIVS-II sequences, but not the splicing reaction. The placement of betaIVS-II in the IVS-I position did not reduce the efficiency of 3' cleavage indicating that the distance between the necessary element(s) in this intron and the polyadenylation recognition site is not a crucial factor. Subsequent placement of betaIVS-I in the intron II position, reduced the efficiency of 3'-end formation to only 16% of normal. A direct replacement of intron II by the heterologous introns betaIVS-I or alpha-globin IVS-II, only partially substitute (16 and 30% respectively) for betaIVS-II. Hybrid introns show that efficient 3'-end formation is strongly enhanced by the presence of the terminal 60 nt of betaIVS-II. These data imply that the last intervening sequence of multiple intron containing genes is a principal determinant of the efficiency of 3'-end formation and may act as a post-transcriptional regulatory step in gene expression.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Miccio, R. Cesari, F. Lotti, C. Rossi, F. Sanvito, M. Ponzoni, S. J. E. Routledge, C.-M. Chow, M. N. Antoniou, and G. Ferrari
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of {beta}-thalassemia
PNAS, July 29, 2008; 105(30): 10547 - 10552.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Rigo and H. G. Martinson
Functional Coupling of Last-Intron Splicing and 3'-End Processing to Transcription In Vitro: the Poly(A) Signal Couples to Splicing before Committing to Cleavage
Mol. Cell. Biol., January 15, 2008; 28(2): 849 - 862.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
P. Malik and P. I. Arumugam
Gene Therapy for {beta}-Thalassemia
Hematology, January 1, 2005; 2005(1): 45 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. M. Salati, W. Szeszel-Fedorowicz, H. Tao, M. A. Gibson, B. Amir-Ahmady, L. P. Stabile, and D. L. Hodge
Nutritional Regulation of mRNA Processing
J. Nutr., September 1, 2004; 134(9): 2437S - 2443S.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
N. CUSTODIO, C. CARVALHO, I. CONDADO, M. ANTONIOU, B. J. BLENCOWE, and M. CARMO-FONSECA
In vivo recruitment of exon junction complex proteins to transcription sites in mammalian cell nuclei
RNA, April 1, 2004; 10(4): 622 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J C Sanchez-Gutierrez, T Benlloch, M A Leal, B Samper, I Garcia-Ripoll, and J E Feliu
Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain
J. Med. Genet., September 1, 2002; 39(9): e56 - 56.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tao, W. Szeszel-Fedorowicz, B. Amir-Ahmady, M. A. Gibson, L. P. Stabile, and L. M. Salati
Inhibition of the Splicing of Glucose-6-phosphate Dehydrogenase Precursor mRNA by Polyunsaturated Fatty Acids
J. Biol. Chem., August 16, 2002; 277(34): 31270 - 31278.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Shayakhmetov, C. A. Carlson, H. Stecher, Q. Li, G. Stamatoyannopoulos, and A. Lieber
A High-Capacity, Capsid-Modified Hybrid Adenovirus/Adeno-Associated Virus Vector for Stable Transduction of Human Hematopoietic Cells
J. Virol., February 1, 2002; 76(3): 1135 - 1143.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Moreau-Gaudry, P. Xia, G. Jiang, N. P. Perelman, G. Bauer, J. Ellis, K. H. Surinya, F. Mavilio, C.-K. Shen, and P. Malik
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors
Blood, November 1, 2001; 98(9): 2664 - 2672.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Zertal-Zidani, R. Ducrocq, C. Weil-Olivier, J. Elion, and R. Krishnamoorthy
A novel {delta}{beta} fusion gene expresses hemoglobin A (HbA) not Hb Lepore: Senegalese {delta}0{beta}+ thalassemia
Blood, August 15, 2001; 98(4): 1261 - 1263.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. E. Rubin, P. Pasceri, X. Wu, P. Leboulch, and J. Ellis
Locus control region activity by 5'HS3 requires a functional interaction with beta -globin gene regulatory elements: expression of novel beta /gamma -globin hybrid transgenes
Blood, May 15, 2000; 95(10): 3242 - 3249.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
J. Zhao, L. Hyman, and C. Moore
Formation of mRNA 3' Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis
Microbiol. Mol. Biol. Rev., June 1, 1999; 63(2): 405 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Zufferey, J. E. Donello, D. Trono, and T. J. Hope
Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors
J. Virol., April 1, 1999; 73(4): 2886 - 2892.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. R. Provost and Y. Tremblay
Length Increase of the Human alpha -Globin 3'-Untranslated Region Disrupts Stability of the Pre-mRNA but Not That of the Mature mRNA
J. Biol. Chem., September 22, 2000; 275(39): 30248 - 30255.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Amir-Ahmady and L. M. Salati
Regulation of the Processing of Glucose-6-phosphate Dehydrogenase mRNA by Nutritional Status
J. Biol. Chem., March 23, 2001; 276(13): 10514 - 10523.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.